Luis Soenksen Martínez is a biomedical engineer from Mexico City, Mexico. He holds a bachelor’s degree in biomedical engineering from the Monterrey Institute of Technology in Mexico, and a master’s of science and engineering in bioengineering innovation and design from Johns Hopkins University. His training includes medical technology prototyping, manufacturing, bench/clinical testing, regulatory affairs, quality systems, reimbursement and market research.Luis has been interested in biomedical imaging since he was an undergraduate at the Monterrey Institute of Technology, where he studied the refinement of non-ionizing techniques and post-processing tools in ultrasound, MRI, X-ray, CT, PET, and SPECT/CT for cardiovascular medicine.Luis performed clinical-need driven research at the Mexican National Institute of Cardiology. His work there led him to code investigational modeling software to develop novel applications for patients suffering from microvascular obstruction, pulmonary embolism, and blindness. His research was published internationally, and led to a prototype of a patented “guidance system for the blind.” It also led to software to evaluate cardiac synchrony in PET images through Ventricular Phase Analysis, which was evaluated in over 4500 patients at Yale University in 2011. Since earning his masters in 2012, Luis has created nine patented biomedical technologies, two start-up companies, received grant funding, and improved patient care internationally.
Previous to becoming an M+Visión Fellow, Luis worked as a lead R&D engineer and strategy specialist for Alandra Medical, a medical device design and development firm, where he has collaborated to develop four innovative products from concept towards commercialization. He looks forward to strengthening his relationship with the Spanish and Boston biomedical clusters, and believes that the future of medicine lies in solutions that allow clinicians to understand the state of patients, and to monitor and treat them after diagnosis. He hopes “to disrupt markets, to bend the limits of what is now possible and to change medicine forever and for good.”
UPDATE, AUTUMN 2015
PhD student in Mechanical Engineering at MIT
“I’m working on improving Human Physiome on a Chip platforms, by joining the Physio-Mimetics program which combines tissue engineering, hardware engineering, and translational system pharmacology technologies to create a versatile microfluidic platform that can incorporate up to 10 individual engineered human microphysiological organ system modules in an interacting circuit. The modules are designed to mimic the functions of specific organ systems representing a broad spectrum of human tissues, including the circulatory, endocrine, gastrointestinal, immune, integumentary, musculoskeletal, nervous, reproductive, respiratory and urinary systems. The goal of the program is to create a versatile platform capable of accurately predicting drug and vaccine efficacy, toxicity, and pharmacokinetics in preclinical testing. The team anticipates that the platform will be suitable for use in regulatory review, amenable to rapid translation to the biopharmaceutical research community, and adaptable for integration of future technologies (such as advances in stem cell technologies and personalized medicine).”